Alzheimer's disease

Alzheimer's and iboga. What is known, what is not, and how we can help.

Whether you are in the early stage of Alzheimer's or reading this for a parent, you are welcome here. The plain truth first: no study has ever tested iboga in Alzheimer's, in people or in animals, and no one can promise it will slow the disease. What we offer is a traditional ceremony, a physician on site day and night, and a medical team that plans the retreat around your health.

  • No studyof iboga or ibogaine in Alzheimer's, in people or in animal models
  • 24/7physician on site
  • Early stagestrongly recommended: you decide for yourself, and come with a companion
Cover of the free guide While You Can Choose

Free guide · PDF

While You Can Choose

Alzheimer's: the ceremony, the numbers, the research and how to prepare.

Scroll to explore

How we can help

A careful ceremony, planned around your memory and your health

A diagnosis of Alzheimer's or mild cognitive impairment changes how a person sees the years ahead, and it changes the whole family. People who come to us at this stage rarely come for a cure. They come for the ceremony itself: to look back over a life, to face the fear, and to decide how to live the time ahead. A retreat with us holds all of it: the medicine and the ceremony for the mind and the spirit, a medical team for the body, and three months of follow-up.

We will not promise to slow, stop or reverse Alzheimer's, and no one honestly can. Iboga does not replace your memory medicines, your neurologist or your memory clinic. In the tradition you come without expectations; what we can promise is careful preparation, a team at your side all night, and honesty about what is known.

The mechanism

What Alzheimer's does to the memory centre, and where iboga's alkaloids would arrive

New memories are made in the hippocampus, a small curved area deep inside each side of the brain. Its nerve cells talk to each other across tiny connections called synapses. In Alzheimer's, a protein called amyloid gathers between the cells as plaques, a protein called tau twists into tangles inside them, connections are lost, and recent memories begin to slip.

Iboga's main alkaloid, ibogaine, is turned by the liver into noribogaine, which stays in the body for days. In rats, ibogaine raised some of the brain's own growth factors, in brain areas other than the memory centre. No one has tested any of this in Alzheimer's, in animals or in people. The animation shows the disease and the arrival of the alkaloids; its last step shows only what the growth-factor studies in rats suggest, and no change for the person.

The alkaloids in iboga root bark

  • Ibogaine

    The main alkaloid. Acts on dopamine, serotonin, opioid, NMDA and sigma-2 receptors, and is the one studied for growth factors.

  • Noribogaine

    Made from ibogaine by the liver. Half-life of 28 to 49 hours in healthy volunteers, which is why the effects last beyond the night.

  • Ibogamine, ibogaline and others

    Present in the whole root bark, less studied. One reason a ceremony with the root is not the same as a pill of ibogaine.

The memory centre, in motion

What Alzheimer's does to the memory centre, and where iboga's alkaloids would arrive

Illustrative

Step 4 · Growth factors, in animalsIn rats, one dose of ibogaine raised the brain's instructions for growth factors such as BDNF and GDNF (the faint golden glow), but the BDNF protein itself did not rise significantly, and GDNF protein rose in one area only. None of these studies looked at the memory centre or used an Alzheimer's model. Nothing has been measured in Alzheimer's, so the picture shows no change in what the person notices.

The memory centre, Alzheimer's and iboga's alkaloids A small drawing of a head shows the memory centre, the hippocampus, deep in the brain; the main picture zooms into it. Five nerve cells pass signals to each other along their connections, called synapses. In Alzheimer's, amyloid plaques appear between the cells, tau tangles form inside two of them, four of the seven connections fade and fewer signals pass. Iboga's alkaloids then arrive from the bloodstream: ibogaine, turned by the liver into long-lasting noribogaine. In the last step a faint glow of growth factors appears around the cells, showing only what animal studies on growth factors suggest; this has never been tested in Alzheimer's. A strip below shows six everyday things a person remembers: a key, a face, a calendar, a phone, a cup and a house. They dim in Alzheimer's, do not change when iboga arrives, and stay dim in the last step, because nothing has been studied in Alzheimer's. A conceptual animation, not a scan or a measured result. Where it happens Deep in the brainshown up close on the right Bloodstream Memory centrehippocampus Connectionssynapses Plaquesamyloid, between cells Tanglestau, inside cells Iboga's alkaloidsibogaine, then noribogaine Growth factors, in animalswhat animal studies on growth factors suggest;never tested in Alzheimer's What the person notices In Alzheimer's: never studied Signals between cellsIllustrative, not a measurement
  • A signal, passing between cells
  • A nerve cell in the memory centre
  • A plaque: amyloid, between cells
  • A tangle: tau, inside a cell
  • An iboga alkaloid molecule
  • Faint golden glow: growth factors, as seen in rats; never tested in Alzheimer's
A conceptual sequence, not a brain scan, a measured human response or a treatment result. The growth-factor findings come from research in rats, in brain areas other than the memory centre, and have never been tested in Alzheimer's. Read the rat study ↗

The science in plain words

Why people ask about iboga and Alzheimer's

None of what follows shows that iboga helps in Alzheimer's. These are the threads that lead people to ask the question, and some of them may point the other way. We describe all of it as theory.

We strongly recommend an early stage for one reason above all: the person who comes should be able to understand the ceremony, choose it, and say yes or no for themselves.

Read it honestly

What we do not know

If you read elsewhere that a clinic "reverses" Alzheimer's or dementia with iboga, ask for the published data: we could not find any. We would rather tell you less and be right. See iboga vs ibogaine and how iboga works.

Who can come

Early stage strongly recommended. Every file reviewed by our medical team.

Alzheimer's changes the medical picture: memory medicines, the heart, night-time confusion, balance and the ability to decide all matter for iboga. Our physician reviews every application before anything is confirmed, and decides with you whether and how a retreat can be planned. Sometimes the answer is no, or not yet, and we will say so plainly.

Never stop or change a prescribed medicine on your own. Our physician plans every change with you and your doctors, sometimes weeks in advance.

These requests help us prepare; they are not medical promises. The physician's review decides how the retreat is planned for you. More on preparation and the medical protocol.

For sons and daughters

If you are reading this for a parent

Many of the people who first contact us about Alzheimer's are the children of the person who lives with it. You are welcome on every step: on the discovery call, in gathering the records, and on the trip itself as their companion. The decision must be your parent's own, made while they can understand it, and the medical review is the same for everyone.

  1. Talk with your parent first

    Share this page with them. A retreat only makes sense if they want it for themselves.

  2. Book a call together

    Ask every question, with your parent beside you. Book a discovery call.

  3. Gather the records

    The neurologist's letter, the medication list and a recent ECG.

  4. Apply, and wait for the medical review

    Our physician reads the file, speaks with your parent, and tells you plainly whether a retreat is safe to plan.

Who holds it

Practitioners for the ceremony, a physician and a psychologist for the body and mind

Practitioners initiated in Gabon hold the ceremony. Our physician and psychologist hold the body and the mind, and Lisa is your one contact from first call to flight home. Meet everyone on the team page.

  • Michael Cassidy Mboma
    Michael Cassidy MbomaMissoko Bwiti practitioner. Sets and paces every dose, and guides each guest through the life review during the night.
  • Dr Paola Villarreal
    Dr Paola VillarrealPhysician. Reviews your records and medicines, clears you, runs the cardiac protocol.
  • Tania
    TaniaPsychologist. Preparation, integration, four calls over the three months after you fly home.

Your stay

From the first call to three months after

  1. Before

    Medical review of your file, your neurologist's letter, an ECG and bloodwork, a plan for your medicines, a conversation with you about consent, and a call with the psychologist.

  2. The ceremony nights

    The root is given in steps, the practitioner watching you before giving more, the physician in the room all night, your companion close by. See the ceremony.

  3. Processing and integration days

    Rest, a calm routine, gentle movement at your own pace, talking through the night's life review, time in nature at the cenote.

  4. Three months after

    Four integration calls over three months, with your companion if you wish, specialist follow-up at one and three months, and a summary for your neurologist if you want one. Your usual care, your medicines and your memory clinic carry on.

Dates

Next retreats

Ten or fourteen days on the neurological program, from the same arrival date, eight guests each; full list on the schedule. Apply early: the medical review of an Alzheimer's file can take a little longer.

The neurological program

A specialist team built around your condition

Parkinson's, Alzheimer's and multiple sclerosis each need more than a standard retreat. On the neurological program, specialists in your condition join our physician before you travel, while you are with us and after you go home, and they work with your own neurologist. Ten or fourteen days, in a private room, so there is time to settle, adjust and be observed.

Neurological program · US dollars, per person

  • 10 days$11,500three ceremonies · private room
  • 14 days$15,900three or four ceremonies · private room

Everything in our standard program, plus the specialists and care listed here. The $500 deposit is refunded in full if our medical team cannot clear you.

  • Specialist review before you travelYour records and medicines read by a specialist in your condition, then a video consultation with you and your family.
  • A night nurse on ceremony nightsOne-to-one, at your bedside, on top of the physician on site around the clock.
  • Assessments before and afterMovement, memory or walking measured on arrival and before you leave, in a report for your neurologist.
  • Your medicines, kept on scheduleTimed doses, swallowing and balance checked daily; nothing is stopped without your doctors.
  • A companion welcomeA family member can stay with you; ask on your call for the companion rate.
  1. BeforeRecords, medicines, a video callThe specialist and our physician agree on your plan with your neurologist.
  2. At the centerWatched day and nightBaseline tests, daily checks, a nurse at your side during each ceremony.
  3. AfterFollow-up at one and three monthsThe same tests again, a written report, and the specialist on call.

With every neurological guest: our physician around the clock, a cardiologist for the ECG before and the heart monitoring during ceremonies, and our psychologist, Tania González.

Questions about Alzheimer's

Straight answers

Can iboga cure, slow or reverse Alzheimer's?

No one can promise that, and we will not. Iboga, ibogaine and noribogaine have never been tested in Alzheimer's or mild cognitive impairment, in people or in animal models. It is not a treatment for Alzheimer's.

Then why would someone with Alzheimer's come?

For the ceremony itself: a life review, room for the fear and grief of the diagnosis, and time to decide how to live the years ahead. Some people want to do this while they can still fully choose it. Come for that, not for a change in memory.

Why do you recommend an early stage?

Because the person must understand the ceremony and choose it for themselves, and because night-time confusion, falls, swallowing and medicines are usually simpler early on. Every file is still reviewed individually by our medical team, and a companion is required.

Should I stop donepezil or my other medicines before coming?

Never on your own. Declare every medicine on your health form. Our physician decides with you and your neurologist what continues, what is adjusted and when. Memory medicines that slow the heart, medicines that affect heart rhythm and anti-amyloid infusions need particular planning.

Is it safe for an older person with memory loss?

Age alone does not decide it; the heart, the medicines, the risk of confusion and the overall health do. Ibogaine affects heart rhythm, so every guest has an ECG and bloodwork before travel and cardiac monitoring during the ceremony. Our physician may decline, or ask for more tests, and will explain why.

Can my son or daughter come with me?

Yes, and with Alzheimer's or mild cognitive impairment a companion is required. Tell us early so we can plan their trip to Cancún and home again with you.

What if the medical team says no?

Then your deposit is refunded in full, and we tell you why. Sometimes the answer is a later date, after a medicine change or more tests.

Sources

The research behind this page

  1. Peng S, Wuu J, Mufson EJ, Fahnestock M. Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease. Journal of Neurochemistry 2005;93(6):1412-1421. Read ↗
  2. Marton S, González B, Rodríguez-Bottero S, et al. Ibogaine administration modifies GDNF and BDNF expression in brain regions involved in mesocorticolimbic and nigral dopaminergic circuits. Frontiers in Pharmacology 2019;10:193. Read ↗
  3. He DY, McGough NN, Ravindranathan A, et al. Glial cell line-derived neurotrophic factor mediates the desirable actions of the anti-addiction drug ibogaine against alcohol consumption. Journal of Neuroscience 2005;25(3):619-628. Read ↗
  4. Bowen WD, Vilner BJ, Williams W, Bertha CM, Kuehne ME, Jacobson AE. Ibogaine and its congeners are sigma 2 receptor-selective ligands with moderate affinity. European Journal of Pharmacology 1995;279(1):R1-R3. Read ↗
  5. Vilner BJ, Bowen WD. Modulation of cellular calcium by sigma-2 receptors: release from intracellular stores in human SK-N-SH neuroblastoma cells. Journal of Pharmacology and Experimental Therapeutics 2000;292(3):900-911. Read ↗
  6. Steinfield SR, Stenn DF, Chen H, Kalisch BE. A review of the clinical progress of CT1812, a novel sigma-2 receptor antagonist for the treatment of Alzheimer's disease. Pharmaceuticals 2025;18(5):659. Read ↗
  7. Popik P, Layer RT, Fossom LH, et al. NMDA antagonist properties of the putative antiaddictive drug, ibogaine. Journal of Pharmacology and Experimental Therapeutics 1995;275(2):753-760. Read ↗
  8. Cherian KN, Keynan JN, Anker L, et al. Magnesium-ibogaine therapy in veterans with traumatic brain injuries. Nature Medicine 2024;30(2):373-381. Read ↗
  9. Glue P, Lockhart M, Lam F, Hung N, Hung CT, Friedhoff L. Ascending-dose study of noribogaine in healthy volunteers: pharmacokinetics, pharmacodynamics, safety, and tolerability. Journal of Clinical Pharmacology 2015;55(2):189-194. Read ↗
  10. ClinicalTrials.gov, search for ibogaine and noribogaine studies, checked November 6, 2026. Read ↗

Bring back your inner fire

You've carried this long enough. Start with a conversation with our medical team.

Free guide, PDF

The Bwiti Life guide

  • Who holds your ceremony
  • The tradition and the medicine
  • What the research shows
  • How to prepare, day by day
This package is for
Program length